About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
AGRX - Agile Therapeutics| Previous Close | $1.84 | Open | $1.83 |
| Volume | 1.38M | Market Cap | 161.24M |
| Yield | Last Dividend |
| Agile Therapeutics (NASDAQ:AGRX) Posts E... | 03/02/21 |
| Agile Therapeutics (NASDAQ:AGRX) announced its quarterly earnings results on Sunday. The specialty pharmaceutical company reported ($0.20) EPS for the... | |
| Agile Therapeutics to Participate in Fir... | 01/04/21 |
| PRINCETON, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Chairman and... | |
| Hormonal Contraception Market Analysis b... | 12/16/20 |
| A complete study of the global Hormonal Contraception market is carried out by the analysts in this report, taking into consideration key factors like... | |
| Agile Therapeutics Announces Nationwide ... | 12/07/20 |
| Once-Weekly Twirla is the first and only contraceptive patch that combines levonorgestrel and ethinyl estradiol (EE) PRINCETON, N.J., Dec. 07, 2020 (G... | |
| Agile Therapeutics??? (AGRX) ???Buy??? R... | 11/19/20 |
| Royal Bank of Canada reissued their buy rating on shares of Agile Therapeutics (NASDAQ:AGRX) in a research note issued to investors on Monday morning,... | |
| Agile Therapeutics Analyst Valuation and... | 10/26/20 |
| Agile Therapeutics announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| Agile Therapeutics (NASDAQ:AGRX) Downgra... | 10/23/20 |
| Agile Therapeutics (NASDAQ:AGRX) was downgraded by research analysts at BidaskClub from a ???hold??? rating to a ???sell??? rating in a research repor... | |
| Agile Therapeutics (NASDAQ:AGRX) Rating ... | 10/22/20 |
| Agile Therapeutics (NASDAQ:AGRX) was downgraded by equities research analysts at BidaskClub from a ???hold??? rating to a ???sell??? rating in a resea... | |
| BidaskClub Downgrades Agile Therapeutics... | 10/20/20 |
| Agile Therapeutics (NASDAQ:AGRX) was downgraded by research analysts at BidaskClub from a ???hold??? rating to a ???sell??? rating in a research note ... | |
| Contraceptive Devices Market Projected t... | 10/07/20 |
| Global Contraceptive Devices Market Analysis to 2025 is a specialized and in-depth study of the Contraceptive Devices industry with a focus on the glo... | |
| Agile Therapeutics Announces Virtual Inv... | 09/08/20 |
| Company to Present Twirla?? Commercial Plan Webcast Scheduled from 11:00 am ??? 1:00 pm EDT PRINCETON, N.J., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Agile?... | |
| Is the Options Market Predicting a Spike... | 05/07/20 |
| Investors need to pay close attention to Agile Therapeutics (AGRX) stock based on the movements in the options market lately. | |
| Agile Therapeutics Reports First Quarter... | 05/05/20 |
| FDA Approved Twirla?? Expected to Reach Wholesalers in the Fourth Quarter of 2020 $93.9 Million in Cash and Cash Equivalents as of March 31, 2020 ??? | |
| The Week Ahead In Biotech: Smid-Cap Earn... | 05/03/20 |
| Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma nam... | |
| Is Agile Therapeutics (AGRX) Stock Outpa... | 02/21/20 |
| Is (AGRX) Outperforming Other Medical Stocks This Year? | |
| Agile Therapeutics EPS misses by $0.02 | 02/20/20 |
| Agile Therapeutics (NASDAQ:AGRX): Q4 GAAP EPS of -$0.10 misses by $0.02. Cash and equivalents of $34.5M. Shares -14.3%. Press Release | |
| Agile Therapeutics Reports Fourth Quarte... | 02/20/20 |
| Current Cash and Cash Equivalents Expected to Meet Projected Operating Requirements through End of 2020 Twirla??, Company???s Lead Product Candidate,?... | |
| Why This Analyst Sees New Contraceptive ... | 02/18/20 |
| No summary available. | |
| The Week Ahead In Biotech: Agile, Baudax... | 02/16/20 |
| Biotech stocks were quiet in the week ending Feb. 14 amid some data readouts at a couple of conferences and earnings news flow from smid-cap companies... | |
| The Daily Biotech Pulse: Deciphera Cance... | 02/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 12) ... | |
| The Daily Biotech Pulse: J&J Intensifies... | 02/12/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 11) ... | |
| Stock Alert: Agile Therapeutics (AGRX) | 02/11/20 |
| Shares of Agile Therapeutics, Inc. (AGRX) continue to hit new highs as the Company gears up for a major regulatory catalyst this week.. | |
| Agile Finalizes $35M Term Loan Facility ... | 02/11/20 |
| Agile Therapeutics Inc (NASDAQ: AGRX ) shares are advancing Tuesday after the company announced clinching of a term loan facility. The micro-cap biote... | |
| Attention Biotech Investors: Mark Your C... | 02/03/20 |
| Biotech stocks have come under some selling pressure in the new year. However, January did witness some strong stock-specific upward moves, especially... | |
| The Daily Biotech Pulse: Sanofi Reports ... | 01/30/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 29) ... | |
| The Daily Biotech Pulse: Novartis Earnin... | 01/29/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 28) ... | |
| Agile Therapeutics: 400%+ Upside | 01/22/20 |
| Agile Therapeutics, Inc. is a ~$160 million market capitalization pre-revenue biotech company. The company's lead product, the Twirla contraceptive pa... | |
| Over 400% Potential Upside With Agile Th... | 01/22/20 |
| Agile Therapeutics, Inc. is a ~$160 million market capitalization pre-revenue biotech company.The company's lead product, the Twirla contraceptive pat... | |
| The Daily Biotech Pulse: Xeris Jumps On ... | 01/07/20 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs o... | |
| The Daily Biotech Pulse: Acorda Surges A... | 01/03/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 2) A... | |
| Date | 2021-03-01 (AMC) | Est. (EPS/Rev.) | ($0.22)/ 1.01M |
| Actual (EPS/Rev.) | $-0.20/ $749.00 K | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Tech Trades | Tech Trades | 81.00 % | Follow |
| Arbitrage Trade Analytics | Royce Wells | 72.00 % | Subscribe |
| Swing Trading Cheap Stocks <~ $10 | Michael S. DeVries | 70.00 % | Follow |
| R R Investments | Roland Van Rij | 46.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
